XLO XILIO THERAPEUTICS INC
FollowCOM (common), issuer CIK 1840233
25 managers (26 13F filers) reported a position in XLO shares at 2026-06-30, 2,756,913 shares in all. 11 filers opened a position and 7 filers sold out during the quarter.
- Managers
- 25
- 13F filers
- 26
- New
- 11
- Added
- 4
- Reduced
- 4
- Sold out
- 7
- Shares held by filers
- 2,756,913
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Adage Capital Management, L.P.(group ADAGE CAPITAL PARTNERS GP, L.L.C.)
464,598 shares, 7.06% in a 13G as of 2026-09-30,0000919574-26-007551
Accepted , ingested - Coastlands Capital LP(group Coastlands Capital LP)
731,573 shares, 9.99% in a 13G/A as of 2026-09-30,0001104659-26-127419
Accepted , ingested - ADAR1 Capital Management, LLC(group ADAR1 Capital Management, LLC)
381,000 shares, 9.3% in a 13G as of 2025-09-30,0001104659-26-128741
Accepted , ingested - Logos Global Management LP(group Logos Global Management LP)
730,315 shares, 9.99% in a 13G as of 2025-06-05,0000935836-26-000612
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
ADAR1 Capital Management, LLC and 1 other reporting person reported 381,000 XLO shares, 9.3% of the class, as of 2025-09-30, in a 13G filed 2026-11-16. 0001104659-26-128741
Accepted , ingestedLogos Global Management LP and 5 other reporting persons reported 730,315 XLO shares, 9.99% of the class, as of 2025-06-05, in a 13G filed 2026-11-16. 0000935836-26-000612
Accepted , ingestedCoastlands Capital LP and 4 other reporting persons reported 731,573 XLO shares, 9.99% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-13. 0001104659-26-127419
Accepted , ingestedAdage Capital Management, L.P. and 2 other reporting persons reported 464,598 XLO shares, 7.06% of the class, as of 2026-09-30, in a 13G filed 2026-11-12. 0000919574-26-007551
Accepted , ingested